Low serum angiogenin concentrations in patients with type 2 diabetes

Diabetes Care

Volumn 30, Issue 12, 2007, Pages 3086-3087

  Siebert, Janusz ^a   Reiwer Gostomska, Magdalena ^a   Babińska, Zofia ^a   Myśliwska, Jolanta ^a   Myśliwski, Andrzej ^a   Skopińska Rózewska, Ewa ^b   Sommer, Ewa ^b   Skopiński, Piotr ^b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIN; TRIACYLGLYCEROL;

ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HUMAN; IN VIVO STUDY; INFECTION; KIDNEY DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; RETINOPATHY; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANGIOGENESIS INDUCING AGENTS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MIDDLE AGED; REFERENCE VALUES; RIBONUCLEASE, PANCREATIC;

EID: 37149045056     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-0629     Document Type: Article

References (13)

1. Stitt AW, McGoldrick C, Rice-McCaldin A, McCance DR, Glenn JV, Hsu DK, Fu-Tong Liu, Thorpe SR, Gardiner TA: Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3. Diabetes 53:857-794, 2005
2. Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinc H, Egrin A: Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 99: 2239-2242, 1999
3. Schiekofer S, Gallasso G, Sato K, Kraus BJ, Walsh K: Impaired revascularization in a mouse model of type 2 diabetes is associated with dysregulation of complex angiogenic-regulatory network. Arteriscler Thromb Vasc Biol 25:1603-1609, 2005
4. Taniyama Y, Morishita R, Hiraoka K, Aoki M, Nakagami H, Yamasaki K, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T: Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes. Circulation 104:2344-2350, 2001
5. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 28 (Suppl. 1): S37-S47, 2005
6. Sidky YA, Auerbach R: Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the g-v-h reaction. J Exp Med 141:1084-1100, 1975
7. Skopiński P, Rogala E, Duda-Król B, Lipińska A, Sommer E, Chorostowska-Wynimko J, Szaflik J, Partyka I, Skopinska- Różewska E: Increased interleukin 18 content and angiogenic activity of sera from diabetic (type 2) patients with background retinopathy. J Diabetes Complications 19:335-338, 2005
8. Skopiński P, Szaflik J, Partyka I, Chorostowska-Wynimko J, Duda-Król B, Lipińska A, Sommer E, Skopinska-Różewska E: Serum in vivo angiogenic activity and some pro-angiogenic cytokine levels in diabetes mellitus type 2 (DM2) patients with or without background retinopathy. Centr Eur J Immunol 32:48 -52, 2007
9. Skopinski P, Szaflik J, Duda-Król B, Nartowska J, Sommer E, Chorostowska-Wynimko J, Demkow U, Skopinska-Rózewska E: Suppression of angiogenic activity of sera from diabetic patients with non-proliferative retinopathy by compounds of herbal origin and sulindac sulfone. Int J Mol Med 14:707-711, 2004
10. Hu G, Riordan JF., Vallee BL: Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities. Proc Natl Acad Sci U S A 91:12096-12100, 1994
11. Hu G: Neomycin inhibits angiogenin-induced angiogenesis. Proc Natl Acad Sci U S A 95:9791-9795, 1998
12. Chou E, Suzuma I, Way KJ, Opland D, Clemont AC, Naruse K, Suzuma K, Bowling NL, Vlahos CJ, Aiello LP, King GL: Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states. Circulation 105:373-379, 2002
13. Chung AWY, Hsiang YN, Matzke LA, McManus BM, van Breemen C, Okon EB: Reduced expression of vascular endothelial growth factor paralleled with the increased angiostatin expression resulting from the upregulatd activities of matrix metalloproteinase-2 and -9 in human type 2 diabetic arterial vasculature. Circ Res 99:140-148, 2006